Poltreg S.A. (WSE:PTG)

Poland flag Poland · Delayed Price · Currency is PLN
30.80
-0.70 (-2.22%)
Jun 27, 2025, 5:00 PM CET
-35.56%
Market Cap 143.63M
Revenue (ttm) 250.00K
Net Income (ttm) -20.83M
Shares Out 4.66M
EPS (ttm) -4.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,696
Average Volume 818
Open 31.90
Previous Close 31.50
Day's Range 30.00 - 33.40
52-Week Range 30.00 - 56.80
Beta 0.98
RSI 29.83
Earnings Date Sep 3, 2025

About Poltreg

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 33
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PTG
Full Company Profile

Financial Performance

In 2024, Poltreg's revenue was 350,000, a decrease of -74.98% compared to the previous year's 1.40 million. Losses were -18.71 million, 38.1% more than in 2023.

Financial Statements

News

There is no news available yet.